Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Active Pharmaceutical Ingredient Market by, Type
6.1 Overview
6.2 Innovative APIs
6.3 Generic APIs


7 Global Active Pharmaceutical Ingredient Market by, Synthesis
7.1 Overview
7.2 Synthetic APIs
7.3 Biotech APIs


8 Global Active Pharmaceutical Ingredient Market by, Type of Drug
8.1 Overview
8.2 Prescription
8.3 Over the Counter


9 Global Active Pharmaceutical Ingredient Market by, Potency
9.1 Overview
9.2 Traditional APIs
9.3 High Potency APIs


10 Global Active Pharmaceutical Ingredient Market by, Therapeutic Application
10.1 Overview
10.2 Cardiovascular Diseases
10.3 Communicable Diseases
10.4 Diabetes
10.5 Oncology
10.6 Pain Management
10.7 Respiratory Diseases
10.8 Other Therapeutic Applications


11 Global Active Pharmaceutical Ingredient Market by, End User
11.1 Overview
11.2 Contract Manufacturing Organization
11.3 Contract Research Organization
11.4 Pharmaceutical & Biotechnology Industry
11.5 Other End Users


12 Global Active Pharmaceutical Ingredient Market by, Geography
12.1 Overview
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 UK
12.3.4 Italy
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Australia
12.4.6 New Zealand
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 UAE
12.6.2 Saudi Arabia
12.6.3 Qatar
12.6.4 Iran
12.6.5 South Africa
12.6.6 Rest of Middle East & Africa


13 Key Developments


14 Company Profiling
14.1 AbbVie Inc
14.1.1 Business Overview
14.1.2 Product/Service Offering
14.1.3 Financial Overview
14.1.4 SWOT Analysis
14.1.5 Key Activities
14.2 AstraZeneca
14.3 BASF SE
14.4 Divi’s Laboratories Limited
14.5 Dr. Reddy’s Laboratories Ltd
14.6 Eli Lilly and Company
14.7 Evonik Industries AG
14.8 F. Hoffmann-La Roche Ltd
14.9 Merck KGaA
14.10 Pfizer Inc
14.11 Sanofi
14.12 Teva Pharmaceutical Industries Ltd
14.13 Viatris Inc